Brief: Imunon Enters Into Crada For Preclinical Studies Of Placcine Modality In Preventive Vaccines Against Lassa Virus
24/08/2023 21:44
Imunon Inc IMNN.O :
* IMUNON ENTERS INTO CRADA FOR PRECLINICAL STUDIES OF
PLACCINE
MODALITY IN PREVENTIVE VACCINES AGAINST LASSA VIRUS
* IMUNON INC - HAS ENTERED INTO A COOPERATIVE RESEARCH AND
DEVELOPMENT AGREEMENT (CRADA)
* IMUNON INC - CRADA WILL EVALUATE IMMUNOGENICITY AND
EFFICACY OF
TWO DNA-BASED LASSA VIRUS VACCINE CANDIDATES IN ANIMAL MODELS
Source text for Eikon: ID:nGNXbc96Zk
Further company coverage: IMNN.O